Thème : Maladie d'Erdheim-Chester (ECD) et histiocytose : le diagnostic n'est qu'un début – De la biologie de la maladie aux options thérapeutiques

Speaker: Oshrat Rokah, PhD
Molecular Research Laboratory
Assuta Medical Center
Tel-Aviv, Israel

Date: Thursday, July 16, 2026
Time: 12:00 PM CDT

Dr. Oshrat Rokah is the head of the Molecular Research Lab at Assuta Medical Center, located in Tel Aviv, Israel. She holds a PhD from the Department of Genetics in the Faculty of Medicine at Tel Aviv University. Dr. Rokah’s group were pioneers in studying microRNA expression in Erdheim-Chester Disease, contributing to a better understanding of the molecular mechanisms underlying the development of the disease and opening new avenues for therapeutic treatment. She works in close cooperation with clinical professionals, physicians, and scientists to target real clinical needs and deficiencies. As part of the dedicated clinic at Assuta Medical Center for histiocytic neoplasms, her lab is investigating the role of epigenetic mechanisms in these neoplasms. Inscrivez-vous ici